PREDNISOLONE TEBUTATE Drug Patent Profile
✉ Email this page to a colleague
When do Prednisolone Tebutate patents expire, and when can generic versions of Prednisolone Tebutate launch?
Prednisolone Tebutate is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in PREDNISOLONE TEBUTATE is prednisolone tebutate. There is one drug master file entry for this compound. Additional details are available on the prednisolone tebutate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PREDNISOLONE TEBUTATE?
- What are the global sales for PREDNISOLONE TEBUTATE?
- What is Average Wholesale Price for PREDNISOLONE TEBUTATE?
Summary for PREDNISOLONE TEBUTATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 43 |
| Patent Applications: | 2,298 |
| DailyMed Link: | PREDNISOLONE TEBUTATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PREDNISOLONE TEBUTATE
US Patents and Regulatory Information for PREDNISOLONE TEBUTATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | PREDNISOLONE TEBUTATE | prednisolone tebutate | INJECTABLE;INJECTION | 083362-001 | Feb 17, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
